KOAN Company Profile and Key Details

The stock is currently trading near its 52-week low $0.00 and $0.02. With a market capitalization of about $58.58 thousand, Resonate Blends, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~3.62). Key stats such as the average daily volume over the past year has been around 4.27 million shares, trading with heavier-than-usual volume. Headquartered in North Bergen, NJ, Resonate Blends, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO James W. Zimbler, the company employs approximately 2 people and listed since March 31, 1993. APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector.

Average 10-day trading volume of 3.48 million shares is below the 3-month average of 5.10 million, indicating normal recent market interest.

Resonate Blends, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.03. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Resonate Blends, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Resonate Blends, Inc. trading at a premium to the broader market with a P/E of -0.03.

Resonate Blends, Inc. trades at a P/E ratio of -0.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.04 and a price-to-book ratio of -0.02 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.04, also above market averages.